Application of Guidelines for Medico-professional Supervision of Workers Exposed to Carcinogenic Action of Wood Dust: CERBois Cohort
NCT ID: NCT02884232
Last Updated: 2016-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
800 participants
OBSERVATIONAL
2012-06-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary purposes are:
* Feasibility evaluation of identification of former and actual professional expositions to wood dust and to various naso-sinusal carcinogenics in case of co-expositions (formaldehyde, chrome, nickel, leather)
* Description of abnormal symptoms identified by occupational doctor and needing an otorhinolaryngology test
* Description of results and examinations induced by nasofibroscopy in symptomatic or asymptomatic individuals: counting of naso-sinusal adenocarcinoma cases
* Evaluation of participation of workers retiring in 2 years after inclusion to medical supervision program
* Evaluation of information flow among different players
* Assessment of costs induced by this targeted screening: direct medical costs (screened pathologies, induced additional examinations…) and indirect costs for company (duration of worker absence for transfer, medical and additional examinations).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles
NCT03839537
Multifaceted Intervention for Protection Against Cotton Dust Exposure Among Textile Workers
NCT03738202
Customized Approaches for Evaluating and Reducing Chemical Exposures From Home Building Materials
NCT05416281
The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers
NCT01599845
Collaborative Study of 1,3 Butadiene Biomarkers
NCT00023140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Workers exposed to wood dust
Nasofibroscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nasofibroscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Actual or former professional exposition to wood dust
* Onset of exposition to wood dust back to more than 30 years (latency \>30 years)
* Cumulated exposition to wood dust longer than 12 months
* Exposition to wood dust during machining tasks (sawing, milling, planing, drilling, bridging) or all documented activities exposing to wood dust concentration \> 1 mg/m3 for 8 hours
* Worker followed by occupational doctor of participant occupational health departments
* Worker accepting medico-professional supervision recommended by guidelines
* Affiliation to social security
Exclusion Criteria
44 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christophe PARIS, Pr
Role: PRINCIPAL_INVESTIGATOR
Centre de Consultations de Pathologies Professionnelles - Hôpitaux de Brabois - CHU de Nancy - France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AHI 33
Bordeaux, , France
Pôle Santé Travail
Lille, , France
Gnmst-Btp
Paris, , France
Ville de Paris
Paris, , France
ACMS
Suresnes, , France
Centres de Consultations de Pathologies Professionnelles
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011/INCA/CERBOIS/PARIS-HERIN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.